Zhejiang Tianyu Pharmaceutical Co Ltd (300702) — Tangible Net Worth Ratio
Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Tangible Net Worth Ratio of 85.0% as of June 2026. This metric is calculated by deducting intangible assets (CN¥540.57 Million) from net assets (CN¥3.61 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Zhejiang Tianyu Pharmaceutical Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Tianyu Pharmaceutical Co Ltd Tangible Net Worth Ratio (2013–2025)
This chart shows how Zhejiang Tianyu Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of June 2026, the ratio stands at 85.0%, reflecting net assets of CN¥3.61 Billion with intangible assets of CN¥540.57 Million CNY. For live market cap and overall valuation, see how much is Zhejiang Tianyu Pharmaceutical Co Ltd worth.
Annual Tangible Net Worth Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Zhejiang Tianyu Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.5% | CN¥3.64 Billion | CN¥491.69 Million | CN¥6.59 Billion | ▼ -0.2 pp |
| 2024 | 86.7% | CN¥3.50 Billion | CN¥464.72 Million | CN¥6.58 Billion | ▼ -0.5 pp |
| 2023 | 87.2% | CN¥3.49 Billion | CN¥445.66 Million | CN¥6.34 Billion | ▼ -0.6 pp |
| 2022 | 87.9% | CN¥3.50 Billion | CN¥423.94 Million | CN¥6.42 Billion | ▼ -2.0 pp |
| 2021 | 89.9% | CN¥3.71 Billion | CN¥374.75 Million | CN¥5.80 Billion | ▼ -3.3 pp |
| 2020 | 93.2% | CN¥3.55 Billion | CN¥241.34 Million | CN¥4.89 Billion | ▲ +1.3 pp |
| 2019 | 91.9% | CN¥2.04 Billion | CN¥165.71 Million | CN¥2.84 Billion | ▲ +2.2 pp |
| 2018 | 89.7% | CN¥1.45 Billion | CN¥149.65 Million | CN¥2.63 Billion | ▲ +1.6 pp |
| 2017 | 88.1% | CN¥1.29 Billion | CN¥153.24 Million | CN¥2.11 Billion | ▲ +6.7 pp |
| 2016 | 81.4% | CN¥607.31 Million | CN¥113.04 Million | CN¥1.52 Billion | ▼ -3.0 pp |
| 2015 | 84.4% | CN¥495.77 Million | CN¥77.44 Million | CN¥1.33 Billion | ▼ -5.0 pp |
| 2014 | 89.4% | CN¥456.22 Million | CN¥48.33 Million | CN¥1.08 Billion | ▲ +0.3 pp |
| 2013 | 89.1% | CN¥453.68 Million | CN¥49.48 Million | CN¥971.79 Million | — |